Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Telmisartan + Amlodipin, (OBG) ATC C09DB04 für die Zeit 01.03.2025 - 28.02.2027

Health · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

December 29, 2026
Response Due
Active
Status

Opportunity Overview

Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient telmisartan + amlodipine, (OBG) ATC C09DB04 for the period 01.03.2025 - 28.02.2027

This Germany Pharmaceuticals opportunity is one most of your competitors will never see.

How to bid: GlobalGov tracks this tender; it does not accept bids. Submit your response through the issuing agency’s official notice.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start a free GlobalGov account

Solicitation Details

Issuing agencyHealth
CountryGermany
CategoryPharmaceuticals
PublishedJanuary 16, 2025
Procurement stageActive solicitation
Response dueDecember 29, 2026
StatusOpen — accepting responses
Original languageGerman — members read it in their own language
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Related Opportunities in Germany

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Promethazin, ATC N05CM22
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Brodalumab, ATC L04AC12
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Colchicin, ATC M04AC01
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Glatirameracetat (ATC: L03AX13)
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Flecainid (ATC: C01BC04)
Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026-02
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Allergenextrakte aus Gräserpollen zur sublingualen Anwendung, Handelsbezeichnung Oralair(R), ATC V01AA02
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Fentanyl in der Darreichungsform Sublingualtabletten und Lutschtabletten, ATC N02AB03

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.